Satellos Bioscience Inc. (MSCLF)
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.
Address
65 FRONT STREET EAST
TORONTO, A6 M5E 1B5
Founded
2012
Number of Employees
12
Website
http://www.satellos.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)